Inventor · disambiguated record
Esteban Masuda
Also filed as: MASUDA ESTEBAN
84 granted patents·28 pending applications·380 citations·filing 2001–2025
99Inventor score
Top patents by PatentIndex Score
112 records- 0197US10975064B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·14 cites·18 claims
- 0297US8163902B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesBHAMIDIPATI SOMASEKHAR·Filed 2007·Granted Apr 24, 2012·35 cites·22 claims
- 0397US7989448B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Aug 2, 2011·35 cites·20 claims
- 0497US7538108B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted May 26, 2009·43 cites·19 claims
- 0596US11332451B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted May 17, 2022·3 cites·13 claims
- 0696US10815206B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·16 cites·17 claims
- 0796US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 0895US8211888B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2011·Granted Jul 3, 2012·19 cites·9 claims
- 0993US11377428B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·2 cites·13 claims
- 1093US11370765B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 1193US11370764B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 1291US7659280B22,4-pyrimidinediamine compounds for treating or preventing autoimmune diseasesRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Feb 9, 2010·19 cites·17 claims
- 1390US8785437B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jul 22, 2014·7 cites·8 claims
- 1489US2025034100A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1588US11919890B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·1 cites·18 claims
- 1688US11110082B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Sep 7, 2021·2 cites·28 claims
- 1788US9566278B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·6 cites·21 claims
- 1888US8476263B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2012·Granted Jul 2, 2013·5 cites·10 claims
- 1987US8227455B2Methods of treating cell proliferative disordersMASUDA ESTEBAN·Filed 2006·Granted Jul 24, 2012·14 cites·40 claims
- 2086US7576053B2Methods and compositions for treating degenerative bone disordersRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Aug 18, 2009·15 cites·31 claims
- 2185US9481654B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·5 cites·19 claims
- 2285US9321763B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Apr 26, 2016·6 cites·64 claims
- 2385US8053434B2Kinase inhibitors and their usesRIGEL PHARMACEUTICALS INC·Filed 2009·Granted Nov 8, 2011·5 cites·42 claims
- 2484US12116354B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Oct 15, 2024·0 cites·21 claims
- 2584US9737554B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Aug 22, 2017·2 cites·11 claims
- 2684US9532998B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2016·Granted Jan 3, 2017·2 cites·24 claims
- 2784US9266912B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 23, 2016·3 cites·24 claims
- 2883US10434096B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Oct 8, 2019·2 cites·6 claims
- 2983US9682976B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·3 cites·55 claims
- 3083US9169249B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Oct 27, 2015·4 cites·17 claims
- 3182US10577381B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 3, 2020·1 cites·24 claims
- 3281US12384775B2Pyrimid-2-yl-pyrazole compounds as IRAK inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted Aug 12, 2025·0 cites·22 claims
- 3381US10130623B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Nov 20, 2018·2 cites·39 claims
- 3481US9913843B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Mar 13, 2018·3 cites·5 claims
- 3581US9593082B2Compositions and methods for inhibition of the JAK pathwayARGADE ANKUSH·Filed 2008·Granted Mar 14, 2017·3 cites·17 claims
- 3681US9283238B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Mar 15, 2016·2 cites·7 claims
- 3781US9181222B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·4 cites·18 claims
- 3881US8710223B2Protein kinase C inhibitors and uses thereofHOLLAND SACHA·Filed 2011·Granted Apr 29, 2014·7 cites·2 claims
- 3981US8530466B2Use of 2,4-pyrimidinediamines for the treatment of atherosclerosisMASUDA ESTEBAN·Filed 2009·Granted Sep 10, 2013·8 cites·1 claims
- 4081US2024217958A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4180US11220496B2Compounds and method for treating autoimmune diseasesRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jan 11, 2022·1 cites·20 claims
- 4280US8912170B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Dec 16, 2014·2 cites·28 claims
- 4380US7425418B2Compounds that modulate processes associated with IgE productionRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Sep 16, 2008·3 cites·20 claims
- 4479US8962643B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Feb 24, 2015·3 cites·25 claims
- 4579US8445485B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesBHAMIDIPATI SOMASEKHAR·Filed 2012·Granted May 21, 2013·2 cites·23 claims
- 4679US7601713B2Kinase inhibitors and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Oct 13, 2009·2 cites·42 claims
- 4779US2022218705A1Compounds and method for treating autoimmune diseasesRIGEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4878US8334297B22,4-pyrimidinediamine compounds for treatment of inflammatory disordersLI HUI·Filed 2010·Granted Dec 18, 2012·5 cites·26 claims
- 4978US2025333408A1Pyrimid-2-yl-pyrazole compounds as irak inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 5077US7056687B2Methods and compositions for screening for altered cellular phenotypesRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jun 6, 2006·4 cites·59 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →